People with diabetes
can have difficulty in self-administering the exact insulin
dose at the correct time to keep blood sugar levels in healthy ranges.
According to a new LSU Pennington Biomedical Research Center study, a novel biomarker might give us answers necessary to create a diagnostic tool for hypoglycemia-associated autonomic failure (HAAF).
No objective diagnostic tool currently exists for this condition, which, if left untreated, can lead to ever-worsening and possibly life-threatening episodes of dangerously low blood sugar.
If a low blood sugar episode occurs, individuals usually begin to feel a range of symptoms such as dizziness, headaches, and nausea that trigger them to seek immediate, potentially life-saving, medical care.